Pre-Market Stock News (September 11, 2007)

Print Email

NYSE will hold a moment of silence for the September 11 anniversary from 9:29 AM to 9:30 AM EST.

(AINV) Apollo Investment will sell 13 million shares of common stock in a secondary offering.
(ABBI) Abraxis Bioscience said that its APP unit received tentative approval for Granisetron Hydrochloride Injection called USP, the generic equivalent of Hoffmann-La Roche’s Kytril Injection.
(AMGN) Amgen has review on its anemia treatments with J&J today.
(ARNA) Arena Pharma announced that an independent echocardiographic data safety monitoring board found no reason to stop ongoing Phase III trial BLOOM.
(AVP) Avon Products named Elizabeth Smith as President of Avon Products.
(BBI) Blockbuster COO resigned.
(CFC) Countrywide is reportedly looking for another cash injection according to reports.
(FLOW) Flow $0.05 EPS vs $0.07 est.
(IMCL) Imclone was able to hit primary endpoints of Erbitux in non-small cell lung cancer prolonged survival rates in conjunction with some chemotherapy; stock trading up some 25%.
(LULU) lululemon traded down 5% after meeting expectations.
(NABI) NABI Biopharma announced the sale of its Nabi Biologics to Biotest AG.
(SEPR) Sepracor and GlaxoSmithKline announced an international alliance for commercialization of Sepracor’s Lunivia; SEPR to receive $20 million milestone, plus up to $155 million in total milestones, plus royalties.
(TTWO) Take-Two Interactive posted slightly narrower losses.
(URGI) United Retail Group Inc. gets $13.70 buyout offer from Redcats Group.

Jon C. Ogg
September 11, 2007